Ledger.Open graph →
SEC Form D · Amendment · filed June 29, 2020

Cingulate Therapeutics

Offering
—
Sold
$26.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Kansas City, KS
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (32)

Bryan Kelley · Rome, GAExecJohn H. Cox · Schaumburg, ILExecGeorge A. Overholser · KIRKLAND, WADirectorChris S. Varin · Colchester, VTDirectorDavid Bartelme · Milwaukee, WIDirectorLaurie A. Myers · Kansas City, MOExecJustin N. Lorino · New York, NYDirectorRonnie Wallace · Rome, GAExec · DirectorAlan Kelley · Durham, NCDirectorJeff J. Hargroves · Kansas City, MODirectorLaurie A. Myers · Kansas City, MOExecJeff Kellam · Longview, TXDirectorDana Arrighi · Orlando, FLDirectorRyan Pineda · Las Vegas, NVExec · DirectorPeter J. Werth · Woodbridge, CTDirectorDavid Scalzo · Orlando, FLExec · DirectorWilliam P. Phelan · Albany, NYExecPatrick J. Gallagher · Flanders, NJDirectorPaul R. Marcus · Boston, MAExecStelios R. Papadopoulos · San Diego, CAExecThomas J. Marusak · Albany, NYDirectorRaul R. Silva · Upper Grandview, NYExecJames A. Henderson · New York, NYExec · DirectorJeff J. Conroy · Norfolk, VADirectorArthur B. Straughn · Cordova, TNDirectorTerrance Berland · Orlando, FLDirectorBrent Adam · Milwaukee, WIDirectorMatthew N. Brams · Houston, TXExec · DirectorShane J. Schaffer · Kansas City, KSExec · DirectorLouis G. Van Horn · Village of Loch Lloyd, MOExecMarious 5. Sjulsen · New York, NYExecCraig S. Gilgallon · Morristown, NJExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗